Surendra K. Ajjarapu - Sep 1, 2022 Form 4 Insider Report for TRxADE HEALTH, INC (MEDS)

Role
CEO, Director, 10%+ Owner
Signature
/s/ Surendra K. Ajjarapu
Stock symbol
MEDS
Transactions as of
Sep 1, 2022
Transactions value $
$0
Form type
4
Date filed
9/16/2022, 04:57 PM
Previous filing
May 23, 2022
Next filing
Mar 28, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDS Common stock Award $0 +51.7K +4.65% $0.00 1.16M Sep 1, 2022 Direct F1, F2
holding MEDS Common stock 213K Sep 1, 2022 Through Surendra Ajjarapu Revocable Trust of 2007 which Reporting Person controls as trustee
holding MEDS Common stock 675K Sep 1, 2022 Through spouse
holding MEDS Common stock 213K Sep 1, 2022 Through Sandhya Ajjarapu Revocable Trust of 2007 which Reporting Person controls as trustee
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on September 30, 2022, October 31, 2022, November 30, 2022 and December 31, 2022, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).
F2 Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as Chief Executive Officer.